Knezović, E.; Hefer, M.; Blažanović, S.; Petrović, A.; Tomičić, V.; Srb, N.; Kirner, D.; Smolić, R.; Smolić, M.
Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom. Curr. Issues Mol. Biol. 2025, 47, 154.
https://doi.org/10.3390/cimb47030154
AMA Style
Knezović E, Hefer M, Blažanović S, Petrović A, Tomičić V, Srb N, Kirner D, Smolić R, Smolić M.
Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom. Current Issues in Molecular Biology. 2025; 47(3):154.
https://doi.org/10.3390/cimb47030154
Chicago/Turabian Style
Knezović, Elizabeta, Marija Hefer, Suzana Blažanović, Ana Petrović, Vice Tomičić, Nika Srb, Damir Kirner, Robert Smolić, and Martina Smolić.
2025. "Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom" Current Issues in Molecular Biology 47, no. 3: 154.
https://doi.org/10.3390/cimb47030154
APA Style
Knezović, E., Hefer, M., Blažanović, S., Petrović, A., Tomičić, V., Srb, N., Kirner, D., Smolić, R., & Smolić, M.
(2025). Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom. Current Issues in Molecular Biology, 47(3), 154.
https://doi.org/10.3390/cimb47030154